Use of recombinant human granulocyte-colony stimulating factor in colorectal surgery

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 18, Issue 11, 1999, Pages 819-822

  Wiik, H T ^a   Syrjala H P ^a   Silvennoinen Kassinen, S H ^b   Laurila, J J ^a   Haukipuro, K A ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL DISEASE; COLORECTAL SURGERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LEUKOCYTOSIS; MALE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PHAGOCYTOSIS; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032761381     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050408     Document Type: Article

References (14)

1. National Nosocomial Infections Surveillance (NNIS) System: Nosocomial infection rates for interhospital comparison: limitations and possible solutions. Infection Control and Hospital Epidemiology (1991) 12:609-621
2. Claesson BEB, Holmlund DEW: Predictors of intraoperative bacterial contamination and postoperative infection in elective colorectal surgery. Journal of Hospital Infection (1988) 11:127-135
3. Lieschke GJ, Burgess AW: Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. New England Journal of Medicine (1992) 327:28-35
4. Roilides E, Walsh TJ, Pizzo PA, Rubin M: Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. Journal of Infectious Diseases (1991) 163:579-583
5. Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, Kris M, Grous J, Picozzi V, Rausch G, Smith R, Gradishar W, Yahanda A, Vincent M, Stewart M, Glaspy J: Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. New England Journal of Medicine (1991) 325:164-170
6. Stoltz DA, Bagby GJ, Nelson S: Use of granulocyte colony-stimulating factor in the treatment of acute infectious diseases. Current Opinion in Hematology (1997) 4:207-212
7. Wilkinson PC: Chemotaxis and inflammation. Churchill-Livingstone, Edinburgh (1982) pp 35-62
8. Glasser L, Fiederlein R: Functional differentiation of normal human neutrophils. Blood (1987) 69:937-944
9. Silver GM, Gamelli RL, O'Reilly M: The beneficial effect of granulocyte colony-stimulating factor [G-CSF] in combination with gentamicin on survival after Pseudomonas burn wound infection. Surgery (1989) 106:452-455
10. Preheim LC, Snitily MU, Gentry MJ: Effects of granulocyte colony-stimulating factor in cirrhotic rats with pneumococcal pneumonia. Journal of Infectious Diseases (1996) 174:225-228
11. Villa P, Shaklee CL, Meazza C, Agnello D, Ghezzi P, Senaldi G: Granulocyte colony-stimulating factor and antibiotics in the prophylaxis of a murine model of polymicrobial peritonitis and sepsis. Journal of Infectious Diseases (1998) 178:471-477
12. Nelson S, Belknap SM, Carlson RW, Dale D, DeBoisblanc B, Farkas S, Fotheringham N, Ho H, Marrie T, Movahhed H, Root R, Wilson J: A randomized controlled trial of Filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. Journal of Infectious Diseases (1998) 178:1075-1080
13. Gross-Weege W, Weiss M, Schneider M, Wenning M, Harms B, Dumon K, Ohmann C, Röher H-D: Safety of a low-dosage Filgrastim (rhG-CSF) treatment in non-neutropenic surgical intensive care patients with an inflammatory process. Intensive Care Medicine (1997) 23:16-22
14. Gough A, Clapperton M, Rolando N, Foster AVM, Philpott-Howard J, Edmonds ME: Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection. Lancet (1997) 350:855-859